Affordable Access

Publisher Website

Davallialactone protects against acetaminophen overdose-induced liver injuries in mice

Food and Chemical Toxicology
DOI: 10.1016/j.fct.2013.04.005
  • Acetaminophen
  • Davallialactone
  • Liver
  • Toxicity
  • Oxidative Stress


Abstract Oxidative stress is closely associated with acetaminophen (APAP)-induced toxicity. Davallialactone (DAVA), a hispidin analog derived from the mushroom Inonotus xeranticus, has antioxidant properties. This study evaluated whether DAVA plays protective roles against APAP hepatotoxicity in mice. Pretreatments with DAVA (10mg/kg) prior to exposures of mice to a hepatotoxic dose of 600mg/kg APAP significantly increased survival rate compared to APAP alone. To verify this effect, mice were treated with 400mg/kg APAP 30min after DAVA administration and were then sacrificed after 0.5, 1, 3, and 6h. APAP alone caused severe liver injuries as characterized by increased plasma GOT and GPT levels, ATP and GSH depletion, and peroxynitrite and 4-HNE formations. These liver damages induced by APAP were significantly attenuated by DAVA pretreatments. The GSH/GSSG ratio nearly recovered to the levels observed in non-APAP-treated mice at 6h after APAP treatment in DAVA-pretreated mice. Furthermore, while hepatic ROS levels were increased by APAP exposures, pretreatments with DAVA completely blocked ROS formation. In addition, APAP-induced sustained activations of JNK and ERK were remarkably reduced by DAVA pretreatment. In conclusion, these results suggest that DAVA plays protective roles against APAP-mediated hepatotoxicity through function as ROS scavenger.

There are no comments yet on this publication. Be the first to share your thoughts.